Abstract
A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous xenograft of a metastatic model of human HCC in nude mice (LCI-D20) by means of alternating cell culture in vitro and growth in nude mice. The line, designated MHCC97, has been cultivated for 18 months and subcultured for more than 90 passages. The line was showed to be of human origin by karyotype analysis. The cells were either grown as compact colonies (in clusters) or as a monolayered sheet with about 31 h of population-doubling time, exhibited typical malignant epithelial in morphology and were positive for α-fetoprotein (AFP). Flow cytometric analysis of the cell DNA content showed an aneuploid pattern, and its index was 1.5 as compared to that of normal human peripheral blood lymphocytes. Karyotypic analyses of G- and C-banding techniques revealed that all cells presented chromosome abnormalities in number and structure. The number of cell line MHCC97 chromosome ranged from 59 to 65 with a modal number of 60 and 61. At least two common chromosome markers, i(1q) and der(4)t(4;?)(4pter→q35::?), were present in all cells, and deletion of Y chromosome also occurred in all cells. The subcutaneous and intrahepatic xenografts were formed and metastatic lesions in lungs were found after the cells were inoculated into nude mice. The rate of metastasis to lungs was 100% using orthotopic inoculation. Reverse transcription polymerase chain reaction products revealed positive expressions of integrin α5 and β1, urokinase type plasminogen activator receptor (uPAR), vascular endothelial growth factor and nm23-H1 mRNAs of cell line MHCC97. Immunostaining of c-Met, uPAR showed strongly positive in both subcutaneous xenografts and lung metastatic lesions; while positive in xenografts and negative in metastatic lesions for integrin α5, β1. E-cadherin and P53 was not expressed either in xenograft or in the metastatic lesions. PCR products of HBsAg and HBxAg were both positive. The cell line MHCC97 still retained some characteristic features of original tumour. Establishment of cell line MHCC97 should be beneficial to the studies of HCC metastatic mechanisms.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Albelda, SM (1993) Role of integrins and other cell adhesion molecules in tumour progression and metastasis. Lab Invest 68: 4–17.
Alexander, JJ, Bey, EM & Lecates, G (1976) Establishment of a continuously growing cell line derived from primary carcinoma of the liver. J South Afr Med 50: 2124–2128.
Amadori, D, Bertoni, L, Flamigni, A, Savini, S, Giovanni, CD, Casanova, S, de Paola, F, Amadori, A, Giulotto, E & Zoli, W (1993) Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat 28: 251–260.
Anderson, BB, Ukah, F, Tette, A, Villaflor, SG, Koh, D & Seton, P (1992) Primary tumors of the liver. J Natl Med Assoc 84: 129–135.
Aznavoorian, S, Murphy, AN, Stetler-Stevenson, WG & Liotta, LA (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368–1383.
Bardi, G, Johanssan, B, Pandis, N, Mandahl, N, Andren-Sandberg, A, Hugerstrand, I & Mitelman, F (1992) Cytogenetic findings in three primary hepatocellular carcinoma. Cancer Genet Cytogenet 58: 191–195.
Bishop, JM (1991) Molecular themes in oncogenesis. Cell 64: 235–248.
Blasi, F (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating migration and invasiveness. Bioassays 15: 105–111.
Bussolino, F, Di Renzo, MF, Ziche, M, Bocchietto, E, Olivero, M, Naldimi, L, Gaudino, G, Tamagnone, L, Coffer, A & Comoglio, PM (1992) HGF is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629
Chen, HL, Chiu, TS, Chen, PJ & Chen, DS (1993) Cytogenetic studies on human liver cancer cell lines. Cancer Genet Cytogenet 65: 161–166.
Chen, RM (1963) The establishment of a strain of human liver carcinoma in vitro and some preliminary observations. Chin Med J 82: 228–237.
Daikuhara, H, Tsubouchi, F, Blasi, F & Comoglis, PM (1992) Extracellular proteolytic cleavage by urokinase is required for activation of HGF/scatter factor. EMBO J 11: 4825–4833.
Dong, RC, Zhou, RH, Lu, FD & Tao, WZ (1980) Establishment of a human hepatocarcinoma cell line SMMC-7721 and initial observations on its biologic characteristics. Acad J Second Millitary Med Univ 1: 5–7.
Ellis, VC, Pyke, C, Eriksen, J, Solberg, H & Dano, K (1992) The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci 667: 13–31.
Fildler, I & Ellis, L (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185–188.
Fourel, G, Trepo, C, Baugueleret, L, Hengliein, B, Ponzetto, A, Tiollais, P & Buendia, MA (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature 347: 274–280.
Frixen, UH, Behrans, HJ & Sacks, K (1991) E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173–185.
Fujimori, M and 12 others (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89–93.
Giancutti, FG & Ruoslahti, E (1990) Elevated level of α5β1 fibronectin receptor suppress the transformed phenotype in CHO cells. Cell 60: 849–859.
Giard, DJ, Aronson, SA, Todaro, GJ, Arnstein, P, Kersey, JH, Dosik, H & Parks, WP (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417–1423.
Grant, DS, Kleinman, HK, Goldgerg, ID, Bhargava, MM, Nichaloff, BJ, Kinsella, JL, Polverini, P & Rosen, EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937–1941.
Hambly, RJ, Double, JA, Thompson, MJ & Bibby, MC (1997) Establishment and characterization of new cell lines from human breast tumors initially established as tumor xenografts in NMRI nude mice. Breast Cancer Res Treat 43: 247–258.
He, L, Isselbacher, KJ, Wands, JR, Goodman, HM, Shih, C & Quaroni, A (1984) Establishment of characterization of a new HCC cell line. In Vitro 20: 493–504.
Hsu, TY, Moroy, T, Etiemble, J, Louise, A, Trepo, C, Tiollais, P & Buedia, MA (1988) Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55: 627–635.
Igawa, M, Rukstalis, DM, Tanabe, T & Chodak, GW (1994) High level of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res 54: 1313–1318.
Jeffers, M, Rong, S & Van Woude, GF (1996) Enhanced tumorigenicity and invasion-metastasis by HGF/SF-Met signaling in human cells consistent with induction of the urokinase proteolysis network. Mol Cell Biol 16: 115–1125.
Koch, AE, Harlow, LA, Haines, GK, Amento, EP, Unemori, EN, Wong, WL, Pope, RM & Ferrara, N (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152: 4149–4156.
Krause, CJ & Beekell, MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured for human squamous cell carcinomas. Cancer Res 41: 1657–1663.
Kuroki, T, Fujiwara, Y, Nakamori, S, Imaoka, S, Kanematsu, T & Nakamura, Y (1995) Evidence for the presence of two tumor-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 72: 383–385.
Liao, SK, Dent, PB & McCulloch, PB (1975) Characterization of human malignant melanoma cell line. I. Morphology and growth characteristics in culture. J Natl Cancer Inst 54: 1037–1044.
Matsumoto, K & Nakamura, T (1996) Emerging multiprotent aspects of hepatocyte growth factor. J Biochem Tokyo 119: 591–600.
Meltzer, P, Leibovita, A, Dalton, W, Villar, H, Kute, T, Davis, J, Nagle, R & Trent, J (1991) Establishment of two new lines derived from human breast carcinomas with HER-2/ueu amplification. Br J Cancer 63: 727–735.
Miyasaka, M (1995) Cancer metastasis and adhesion molecules. Clin Orthop Relat Res 312: 10–18.
Murakami, Y, Hayashi, K, Hirohashi, S & Sekiya, T (1991) Aberration of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res 51: 5520–5525.
Nigam, AK, Pignatelli, M & Boulos, PBC (1994) Current concepts in metastasis. Gut 35: 996–1000.
Nishida, N, Fukuda, Y, Kuroki, H, Sadamoto, T, Isowa, G, Honda, K, Yamaoka, Y, Ikenaga, M, Imura, H & Ishizaki, K (1992) Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 51: 862–868.
Okuda, K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15: 948–963.
Park, JG and 12 others (1990) Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773–2780.
Parkin, DM, Pisani, P & Ferlay, J (1993) Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594–606.
Pasquinelli, C, Garreau, F, Bougueleret, L, Cariani, E, Grzeschik, KH, Thiere, V, Croissant, O, Hadchauel, M, Tiollais, P & Brechot, C (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumour. J Virol 62: 629
Rogler, CE, Sherman, M, Su, CY, Shafritz, DA, Summers, J, Shows, TB, Henderson, A & Kew, M (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science 230: 319–322.
Schreiner, C, Fisher, M, Hussein, S & Juliano, RL (1991) Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res 51: 1738–1740.
Seabright, MA (1971) A rapid banding technique for human chromosomes. Lancet ii: 971–972.
Shimoyama, Y & Hirohashi, S (1991) Cadherin intercellular adhesion molecule in hepatocellular carcinoma: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Letts 57: 131–135.
Simon, D, Munou, SJ, Maddrey, WC & Knowles, BB (1990) Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet 45: 255–260.
Simon, D, Knowles, BB & Weith, A (1991) Abnormalities of chromosome 1 and loss of heterozyosity on 1p in primary hepatomas. Oncogene 6: 765–770.
Sugimura, T (1992) Multistep carcinogenesis: a 1992 prospective. Science 258: 603–607.
Sun, FX, Tang, ZY, Liu, KD, Ye, SL, Xue, Q, Gao, DM & Ma, ZC (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissue. Int J Cancer 66: 239–243.
Tom, BH, Rutzky, LP, Oyasu, R, Tomita, JT, Goldberg, DM & Kahan, BD (1977) Human colon adenocarcinoma cell. II. Tumorigenic and organoid expression in vivo and in vitro. J Natl Cancer Inst 58: 1507–1512.
Weidner, KM, Behrens, J, Vandekerckhove, J & Birdhmeier, W (1990) Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097–2108.
Weinberg, RA (1992) The integration of molecular genetics into cancer management. Cancer 70: 1653–1658.
Werner, M, Nolte, M, Klempanauer, J & Georgii, A (1993) Chromosome 1 abnormalities in hepatocellular carcinoma. Cancer Genet Cytogenet 64: 130–135.
Yeh, SH, Chen, PJ, Chen, HL, Lai, MY, Wang, CC & Chen, DS (1994) Frequent genetic alternations at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res 54: 4188–4192.
Yeh, SH, Chen, PJ, Lai, MY & Chen, DS (1996) Allelic loss on chromosome 4q and 16q in hepatocellular carcinoma: association with elevated α-fetoprotein production. Gastroenterology 110: 184–192.
Zhang, W, Hirohashi, S, Tsuda, H, Shimosato, Y, Yokota, J, Teradam, M & Sugimura, T (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81: 108–111.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tian, J., Tang, Z., Ye, S. et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81, 814–821 (1999). https://doi.org/10.1038/sj.bjc.6690769
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690769
Keywords
This article is cited by
-
A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma
Journal of Nanobiotechnology (2023)
-
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1
Hepatology International (2023)
-
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
BMC Medical Genomics (2022)
-
The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth
Cellular Oncology (2022)
-
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
Experimental Hematology & Oncology (2021)